These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1360903)

  • 1. Antagonism of ethanol withdrawal convulsions in Withdrawal Seizure Prone mice by diazepam and abecarnil.
    Crabbe JC
    Eur J Pharmacol; 1992 Oct; 221(1):85-90. PubMed ID: 1360903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.
    Natolino F; Zanotti A; Contarino A; Lipartiti M; Giusti P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):612-7. PubMed ID: 8938660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal.
    Anton RF; Kranzler HR; McEvoy JP; Moak DH; Bianca R
    Psychopharmacology (Berl); 1997 May; 131(2):123-9. PubMed ID: 9201799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
    Turski L; Stephens DN; Jensen LH; Petersen EN; Meldrum BS; Patel S; Hansen JB; Löscher W; Schneider HH; Schmiechen R
    J Pharmacol Exp Ther; 1990 Apr; 253(1):344-52. PubMed ID: 1970362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
    Ozawa M; Sugimachi K; Nakada-Kometani Y; Akai T; Yamaguchi M
    J Pharmacol Exp Ther; 1994 May; 269(2):457-62. PubMed ID: 7910208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
    Jackson HC; Hansen HC; Kristiansen M; Suzdak PD; Klitgaard H; Judge ME; Swedberg MD
    Eur J Pharmacol; 1996 Jul; 308(1):21-30. PubMed ID: 8836628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    Rundfeldt C; Wlaź P; Hönack D; Löscher W
    J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.
    Löscher W; Hönack D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):452-60. PubMed ID: 1352384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosterone increases severity of acute withdrawal from ethanol, pentobarbital, and diazepam in mice.
    Roberts AJ; Crabbe JC; Keith LD
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):278-84. PubMed ID: 7862907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of isoniazid-induced convulsions by abecarnil in mice tolerant to diazepam.
    Serra M; Ghiani CA; Motzo C; Porceddu ML; Biggio G
    Pharmacol Biochem Behav; 1995 Oct; 52(2):249-54. PubMed ID: 8577786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.
    Jung ME; Wallis CJ; Gatch MB; Lal H
    Alcohol; 2000 Jun; 21(2):161-8. PubMed ID: 10963939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam.
    Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1215-20. PubMed ID: 8263782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
    Verleye M; Heulard I; Gillardin JM
    Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol and diazepam withdrawal convulsions are extensively codetermined in WSP and WSR mice.
    Belknap JK; Crabbe JC; Laursen SE
    Life Sci; 1989; 44(26):2075-80. PubMed ID: 2501607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal.
    Beadles-Bohling AS; Wiren KM
    Genes Brain Behav; 2006 Aug; 5(6):483-96. PubMed ID: 16923153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines.
    Gorin RE; Crabbe JC; Tanchuck MA; Long SL; Finn DA
    Alcohol Clin Exp Res; 2005 Jun; 29(6):939-48. PubMed ID: 15976519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice.
    Beckley EH; Fretwell AM; Tanchuck MA; Gililland KR; Crabbe JC; Finn DA
    Neuropharmacology; 2008 Feb; 54(2):365-74. PubMed ID: 18045626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.